BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 86 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is 15.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $27,000 | -30.8% | 15,978 | -0.2% | 0.01% | -28.6% |
Q2 2022 | $39,000 | -11.4% | 16,007 | 0.0% | 0.01% | +7.7% |
Q1 2022 | $44,000 | -48.2% | 16,007 | +0.3% | 0.01% | -45.8% |
Q4 2021 | $85,000 | -35.6% | 15,962 | +2.1% | 0.02% | -41.5% |
Q3 2021 | $132,000 | -30.9% | 15,633 | 0.0% | 0.04% | -26.8% |
Q2 2021 | $191,000 | -49.6% | 15,633 | 0.0% | 0.06% | -52.5% |
Q1 2021 | $379,000 | – | 15,633 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |